Rallybio Corporation (RLYB) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 212K | 222K | 212K | 212K | 212K | 38K | 299K | 299K | 0 | 228K | 0 | 0 |
| Revenue Growth % | 0% | 484.21% | -29.1% | -29.1% | - | -83.33% | - | - | - | - | - | - |
| Cost of Goods Sold | 3K | 0 | 0 | 0 | 0 | 30K | 0 | 34K | 35K | 114K | 37K | 38K |
| COGS % of Revenue | 1.42% | - | - | - | - | 78.95% | - | 11.37% | - | 50% | - | - |
| Gross Profit | 209K | 222K | 212K | 212K | 212K | 8K | 299K | 265K | -35K | 114K | -37K | -38K |
| Gross Margin % | 98.58% | 100% | 100% | 100% | 100% | 21.05% | 100% | 88.63% | - | 50% | - | - |
| Gross Profit Growth % | -1.42% | 2675% | -29.1% | -20% | 705.71% | -92.98% | 908.11% | 797.37% | 10.26% | 392.31% | 11.9% | 13.64% |
| Operating Expenses | 4.94M | 6.63M | 7.14M | 10.27M | 9.88M | 11.62M | 12.37M | 17.3M | 19.75M | 21.11M | 19.36M | 20.08M |
| OpEx % of Revenue | 2331.13% | 2988.29% | 3366.51% | 4843.87% | 4661.32% | 30568.42% | 4135.45% | 5785.95% | - | 9259.65% | - | - |
| Selling, General & Admin | 6.07M | 2.98M | 2.99M | 4.2M | 4.16M | 4.26M | 4.13M | 4.39M | 6.85M | 5.19M | 6.08M | 6.95M |
| SG&A % of Revenue | 2865.09% | 1341.89% | 1412.26% | 1978.77% | 1960.85% | 11213.16% | 1379.6% | 1467.56% | - | 2275.44% | - | - |
| Research & Development | 68K | 3.65M | 4.14M | 6.07M | 5.72M | 7.36M | 8.24M | 12.91M | 12.9M | 15.92M | 13.29M | 13.13M |
| R&D % of Revenue | 32.08% | 1646.4% | 1954.25% | 2865.09% | 2700.47% | 19355.26% | 2755.85% | 4318.39% | - | 6984.21% | - | - |
| Other Operating Expenses | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.73M | -6.41M | -6.92M | -10.06M | -9.67M | -11.61M | -12.07M | -17.04M | -19.79M | -21.11M | -19.36M | -20.08M |
| Operating Margin % | -2232.55% | -2888.29% | -3266.51% | -4743.87% | -4561.32% | -30547.37% | -4035.45% | -5697.32% | - | -9259.65% | - | - |
| Operating Income Growth % | 51.05% | 44.76% | 42.61% | 40.96% | 51.13% | 45.02% | 37.69% | 15.18% | -7.69% | -23.53% | -2.67% | -14.01% |
| EBITDA | -4.73M | -6.41M | -6.89M | -10.03M | -9.64M | -11.58M | -12.03M | -17M | -19.75M | -21.08M | -19.33M | -20.05M |
| EBITDA Margin % | -2231.13% | -2886.94% | -3250% | -4731.6% | -4548.11% | -30468.42% | -4024.75% | -5685.95% | - | -9243.86% | - | - |
| EBITDA Growth % | 50.94% | 44.65% | 42.75% | 41% | 51.18% | 45.07% | 37.73% | 15.19% | -7.73% | -23.6% | -2.7% | -14.08% |
| D&A (Non-Cash Add-back) | 3K | 3K | 35K | 26K | 28K | 30K | 32K | 34K | 35K | 36K | 37K | 38K |
| EBIT | -4.73M | -6.41M | -6.92M | -10.06M | -9.67M | -11.61M | -12.07M | -17.04M | -19.79M | -21.11M | -19.36M | -20.08M |
| Net Interest Income | 201K | 560K | 462K | 523K | 644K | 811K | 986K | 1.14M | 1.28M | 1.45M | 1.54M | 1.61M |
| Interest Income | 201K | 560K | 462K | 523K | 644K | 811K | 986K | 1.14M | 1.28M | 1.45M | 1.54M | 1.61M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -3.54M | 560K | 22.94M | 354K | 231K | 564K | 600K | 799K | 758K | 870K | 989K | 1.45M |
| Pretax Income | -8.28M | -5.85M | 16.02M | -9.7M | -9.44M | -11.04M | -11.47M | -16.24M | -19.03M | -20.24M | -18.37M | -18.63M |
| Pretax Margin % | -3904.72% | -2636.04% | 7554.72% | -4576.89% | -4452.36% | -29063.16% | -3834.78% | -5430.1% | - | -8878.07% | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -8.28M | -5.85M | 16.02M | -9.7M | -9.44M | -11.04M | -11.47M | -16.24M | -19.03M | -20.24M | -18.37M | -18.63M |
| Net Margin % | -3904.72% | -2636.04% | 7554.72% | -4576.89% | -4452.36% | -29063.16% | -3834.78% | -5430.1% | - | -8878.07% | - | - |
| Net Income Growth % | 12.3% | 47.01% | 239.68% | 40.24% | 50.4% | 45.44% | 37.6% | 12.85% | -9.88% | -24.93% | -0.02% | -5.95% |
| Net Income (Continuing) | -8.28M | -5.85M | 16.02M | -9.7M | -9.44M | -11.04M | -11.47M | -16.24M | -19.03M | -20.24M | -18.37M | -18.63M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.46 | -1.11 | 2.84 | -1.76 | -1.68 | -2.00 | -2.08 | -2.96 | -3.76 | -4.00 | -3.60 | -3.68 |
| EPS Growth % | 13.1% | 44.5% | 236.54% | 40.54% | 55.32% | 50% | 42.22% | 19.57% | -9.3% | -8.7% | 25% | 19.3% |
| EPS (Basic) | -1.46 | -1.11 | 2.84 | -1.76 | -1.68 | -2.00 | -2.08 | -2.96 | -3.76 | -4.00 | -3.60 | -3.68 |
| Diluted Shares Outstanding | 5.69M | 5.28M | 5.63M | 5.61M | 5.6M | 5.58M | 5.57M | 5.52M | 5.1M | 5.08M | 5.07M | 5.05M |
| Basic Shares Outstanding | 5.69M | 5.28M | 5.63M | 5.61M | 5.6M | 5.58M | 5.57M | 5.52M | 5.1M | 5.08M | 5.07M | 5.05M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |